Authors
Latest:
Case Study: Insulin Sensitizers as Enhancers in Diabetes ManagementThe objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
Latest:
Oncology Overview: Tucatinib for Advanced Unresectable or Metastatic HER2-Positive Breast CancerTucatinib is indicated to treat adults with advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer who have already received at least 1 anti-HER2-based regimen in the metastatic setting.
Latest:
Oncology Overview: Investigational Autologous TIL Immunotherapy LN-145 for Cervical CancerStudies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Latest:
Accelerate Time to Specialty Pharmacy Therapy with Digital OptionsDigitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.
Latest:
Semaglutide Carries Potential Risk of Worsening Diabetic RetinopathyDespite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Latest:
2022-2023 Influenza Season Looks to Be SevereOutpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.
Latest:
Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health OutcomesAdditional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Latest:
2022 ACC Consensus on Role of Nonstatin Therapies for LDL-Cholesterol LoweringSince the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.
Latest:
Future Treatment Landscape of MZLClosing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.
Latest:
The Societal Case for Pharmacist Provider StatusBeyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.
Latest:
Wellness Support Group Shows Promise in Reducing BurnoutDiscussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
Latest:
Practice Pearl 3: Reducing Costs of PARPi for Ovarian Cancer TreatmentExperts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.
Latest:
Pharmacists Play a Critical Role in Protecting Patients From Illegal Online Drug SellersAlthough approximately 95% of online drug sellers operate illegally, many consumers may never know the medications they receive are not what they claim to be.
Latest:
Increased Development of RSV Immunoprophylaxis Inhibited by Cost and Acquisition BarriersDespite the growth in vaccine and antibody development for combatting RSV, lower income countries may not reap the benefits.
Latest:
Monkeypox Treatment and Prevention: Stopping the Latest OutbreakThere is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Latest:
Learn to Mitigate Feelings of Burnout and StressLack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.
Latest:
Changing the Game: Pharmacy Students' Perspective on Naloxone OTC ApprovalTo eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
Latest:
This National Glaucoma Awareness Month, Pharmacists Can Have an Unparalleled Impact on Prevention, Treatment of GlaucomaPharmacists can play a key role in providing education and guidance to patients with glaucoma.
Latest:
New CMS Rules Underscore Pharmacists’ Role in Improving Glycemic ManagementThe measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians.
Latest:
Topical Ketamine: A Promising New Avenue for PTSD TreatmentKetamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.
Latest:
Let’s Have a Heart to Heart About Heart FailureInitiating and optimizing heart failure guideline-directed medical therapy is critical to the comprehensive management of heart failure.
Latest:
Pain Management in the ICU Is ComplexFinding the right medication or drug combination for individual patients is critical.
Latest:
Proposed FDA Rule on Patient Medication Information Seeks to Address Prescription Misuse, NonadherenceImproved prescription information could help consumers make better health care decisions and result in cost savings.
Latest:
Mandatory Immunization of Health Care Workers Leads to ControversyLegal issues surfaced once again with the COVID-19 pandemic
Latest:
Gabapentin Presents High Potential for MisuseAlthough the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.
Latest:
Implementing USP <800> Guidelines in Pediatric HospitalsProtecting this vulnerable patient population requires specially designed strategies.
Latest:
Respect State Marijuana Laws Act of 2017 Amends Previous LegislationPast proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.
Latest:
Considerations for RSV Prevention in Special Patient PopulationsOlder adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.
